HOME › DRUGS › AVELUMAB
ACTIVE SUBSTANCE / INN

AVELUMAB

Brand name(s): Bavencio, BAVENCIO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761078
Neuroendocrine Tumors
ACTIVE SUBSTANCE
Avelumab
REGULATORS
FDA · EMA
SPONSORS / MAH
EMD SERONO INC, Merck Europe B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BAVENCIOBLA761078EMD SERONO INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BavencioMerck Europe B.V.Authorised18/09/2017Neuroendocrine Tumors

FULL INTELLIGENCE ON AVELUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →